| Richard Boulay, MD | |
|
1600 St Lukes Blvd, Easton, PA 18045-5671 | |
| (484) 503-4500 | |
| (484) 503-4501 |
| Full Name | Richard Boulay |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 34 Years |
| Location | 1600 St Lukes Blvd, Easton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013926922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | MD048076L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
A vast majority of leaders in health care and health policy believe Medicare has been successful in providing access to care and stable coverage to the elderly and disabled individuals; however only a small percentage think the program has realized its potential to achieve other important goals, like using its leverage as the country's largest purchaser of services to control costs and promote a high performance health system.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.
MilliporeSigma today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation. This launch marks 50 years of providing ultrapure water to scientists in laboratories all over the world.
› Verified 4 days ago
| Entity Name | Family Care Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669563037 PECOS PAC ID: 5395649347 Enrollment ID: O20031121000497 |
News Archive
A vast majority of leaders in health care and health policy believe Medicare has been successful in providing access to care and stable coverage to the elderly and disabled individuals; however only a small percentage think the program has realized its potential to achieve other important goals, like using its leverage as the country's largest purchaser of services to control costs and promote a high performance health system.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.
MilliporeSigma today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation. This launch marks 50 years of providing ultrapure water to scientists in laboratories all over the world.
› Verified 4 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
A vast majority of leaders in health care and health policy believe Medicare has been successful in providing access to care and stable coverage to the elderly and disabled individuals; however only a small percentage think the program has realized its potential to achieve other important goals, like using its leverage as the country's largest purchaser of services to control costs and promote a high performance health system.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.
MilliporeSigma today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation. This launch marks 50 years of providing ultrapure water to scientists in laboratories all over the world.
› Verified 4 days ago
| Entity Name | Star Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033686159 PECOS PAC ID: 7618215237 Enrollment ID: O20190206002009 |
News Archive
A vast majority of leaders in health care and health policy believe Medicare has been successful in providing access to care and stable coverage to the elderly and disabled individuals; however only a small percentage think the program has realized its potential to achieve other important goals, like using its leverage as the country's largest purchaser of services to control costs and promote a high performance health system.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.
MilliporeSigma today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation. This launch marks 50 years of providing ultrapure water to scientists in laboratories all over the world.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Boulay, MD 1600 St Lukes Blvd, Easton, PA 18045-5671 Ph: (484) 503-4500 | Richard Boulay, MD 1600 St Lukes Blvd, Easton, PA 18045-5671 Ph: (484) 503-4500 |
News Archive
A vast majority of leaders in health care and health policy believe Medicare has been successful in providing access to care and stable coverage to the elderly and disabled individuals; however only a small percentage think the program has realized its potential to achieve other important goals, like using its leverage as the country's largest purchaser of services to control costs and promote a high performance health system.
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.
MilliporeSigma today announced the global launch of the Milli-Q® IQ 7000 system, the seventh-generation Milli-Q® water purification innovation. This launch marks 50 years of providing ultrapure water to scientists in laboratories all over the world.
› Verified 4 days ago
Elizabeth K Lamb, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4051 Freemansburg Avenue, Easton, PA 18045 Phone: 610-559-7474 Fax: 610-559-9276 | |
Nancy J Odonnell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3311 Nazareth Rd, Easton, PA 18045 Phone: 610-559-7880 Fax: 610-559-0633 | |
Neil C Blumenthal, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3701 Corriere Rd Ste 22, Easton, PA 18045 Phone: 484-591-7170 Fax: 484-591-7171 | |
Dr. Marilyn Elias Ekonomidis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4051 Freemansburg Ave, Easton, PA 18045 Phone: 484-503-7474 | |
Christopher R Mann, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2005 Fairview Ave, Suite B, Easton, PA 18042 Phone: 610-258-3615 Fax: 610-253-4496 | |
Dr. Christin Marie Gillier, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1700 St Lukes Blvd, Suite 403, Easton, PA 18045 Phone: 484-503-0628 Fax: 484-503-0631 |